Back to search

Article

<i>PCSK9</i> genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study

2018-05-31

Abstract excerpt

<h4>Aims</h4> PCSK9 inhibitors lower LDL cholesterol and are efficacious at reducing risk of vascular disease, however questions remain about potential adverse effects on cognitive function. We examined the association of LDL cholesterol-lowering genetic variants in PCSK9 with continuous measures of cognitive ability <h4>Methods and Results</h4> Six independent SNPs in PCSK9 were used in up to 337,348 individ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d207d6c9-2247-5e34-9899-36f2e7313a46
DOI
10.1101/335877
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>PCSK9</i> genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization studyDOI 10.1101/335877
Select a neighboring publication to make it the new centre.